BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17911199)

  • 1. Acquired hemophilia: a case report of 2 patients with acquired factor VIII inhibitor treated with rituximab plus a short course of steroid and review of the literature.
    Alvarado Y; Yao X; Jumper C; Hardwicke F; D'Cunha N; Cobos E
    Clin Appl Thromb Hemost; 2007 Oct; 13(4):443-8. PubMed ID: 17911199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired Hemophilia of Unknown Etiology in an Elderly Man: Case Report.
    Stephen SE; Loong JLX; Hoong CK; Lim SM; Botross NP
    Am J Case Rep; 2018 Jul; 19():858-863. PubMed ID: 30033442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitor eradication and treatment for acquired hemophilia A.
    Franchini M; Focosi D
    Expert Rev Hematol; 2024 Jun; 17(6):233-240. PubMed ID: 38708599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired hemophilia A treated with rituximab in a 62-year-old female with rheumatoid arthritis: a case-based review.
    Mohamadzadeh D; Assar S; Farsad F
    Reumatismo; 2023 Dec; 75(4):. PubMed ID: 38115777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of patients with acquired inhibitors.
    Sallah S; Aledort L
    J Thromb Haemost; 2005 Mar; 3(3):595-7. PubMed ID: 15748261
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclophosphamide vs rituximab for eradicating inhibitors in acquired hemophilia A: A randomized trial in 108 patients.
    Lévesque H; Viallard JF; Houivet E; Bonnotte B; Voisin S; Le Cam-Duchez V; Maillot F; Lambert M; Liozon E; Hervier B; Fain O; Guillet B; Schmidt J; Luca LE; Ebbo M; Ferreira-Maldent N; Babuty A; Sailler L; Duffau P; Barbay V; Audia S; Benichou J; Graveleau J; Benhamou Y;
    Thromb Res; 2024 May; 237():79-87. PubMed ID: 38555718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bullous pemphigoid is a common associated disorder with acquired haemophilia A.
    Abdul-Halim NA; Ng HJ
    Int J Hematol; 2021 Jan; 113(1):58-62. PubMed ID: 32949372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoadsorption for the Treatment of Acquired Hemophilia: New Observational Data, Systematic Review, and Meta-Analysis.
    Esteves Pereira M; Bocksrucker C; Kremer Hovinga JA; Mueller M; Daskalakis M; Mansouri Taleghani B; Nagler M
    Transfus Med Rev; 2021 Apr; 35(2):125-134. PubMed ID: 33518429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of acquired hemophilia A.
    Collins PW
    J Thromb Haemost; 2007 May; 5(5):893-900. PubMed ID: 17461924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy of acquired hemophilia A.
    Tiede A
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):19-23. PubMed ID: 38066859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxycycline-induced acquired haemophilia A.
    Shah E; Abro C; Zaidi F; Goel R
    BMJ Case Rep; 2021 Oct; 14(10):. PubMed ID: 34598965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-center experience with rituximab as first-line immunosuppression for acquired hemophilia.
    Boles JC; Key NS; Kasthuri R; Ma AD
    J Thromb Haemost; 2011 Jul; 9(7):1429-31. PubMed ID: 21575131
    [No Abstract]   [Full Text] [Related]  

  • 13. Acquired hemophilia: a case report and review of the literature.
    Mulliez SM; Vantilborgh A; Devreese KM
    Int J Lab Hematol; 2014 Jun; 36(3):398-407. PubMed ID: 24750687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term response to rituximab in a patient with acquired hemophilia].
    García-Chávez J; Vela-Ojeda J; García-Manzano A; Majluf-Cruz A
    Rev Invest Clin; 2011; 63(2):210-2. PubMed ID: 21717725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired factor VIII inhibitor caused by solid tumor malignancy.
    de Bear O; McLean K; Siedel J; Rolston A
    Gynecol Oncol Rep; 2023 Aug; 48():101217. PubMed ID: 37576357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab for eradicating inhibitors in people with acquired haemophilia A.
    Remmington T; Smith S
    Cochrane Database Syst Rev; 2021 Aug; 8(8):CD011907. PubMed ID: 34423414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired factor VIII deficiency in prostate adenocarcinoma presenting as multiple hematomas and hemarthrosis.
    Lewis A; Joseph J; Pathak N; Baseri B; Luhrs C
    SAGE Open Med Case Rep; 2020; 8():2050313X20906743. PubMed ID: 32110407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab for eradicating inhibitors in people with acquired haemophilia A.
    Zeng Y; Zhou R; Duan X; Long D
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD011907. PubMed ID: 27387850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anti-CD20 monoclonal antibody rituximab to treat acquired haemophilia A.
    D'arena G; Grandone E; Di Minno MN; Musto P; Di Minno G
    Blood Transfus; 2016 May; 14(2):255-61. PubMed ID: 26509821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Case of an Acquired Factor VIII Inhibitor Complicated by Multiple Treatment-Related Opportunistic Infections and Review of the Literature.
    Hutchinson AL; Tan YL; Kidson-Gerber G
    Case Rep Hematol; 2013; 2013():703027. PubMed ID: 24455336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.